Congress to investigate ‘soaring generic drug prices’
Minority groups raise concerns around FDA’s Proposed Rule on Generic Labeling
- More than three-quarters (76%) of those surveyed say their patients would be at least somewhat confused by multiple labels for the same medicine;
- Eight in 10 (88%) say multiple labels would be very confusing (53%) or somewhat confusing (35%) for themselves; and
- Among prescribers, 60% said the change would have an impact on their willingness to recommend generic drugs in the future.
Ulta Beauty announces addition to board
BOLINGBROOK, Ill. — Ulta Beauty has announced that Michelle Collins, president of business and financial advisory firm Cambium, has been appointed to its board, and as a member of its nominating and corporate governance and audit committees.
“We are delighted to welcome Michelle to Ulta Beauty’s board of directors. Michelle brings extensive experience in corporate finance and deep corporate governance expertise, having served as a member of the board of directors for many public and private companies. I am confident she will make tremendous contributions to Ulta,” said Mary Dillon, Ulta Beauty’s CEO.
Collins joins the board with 28 years of experience in corporate finance and business consulting. She has been the president of Cambium since 2007. Previously, she was managing director and co-founder of Svoboda Capital Partners, a private equity firm, from 1998 to 2007. She began her career in 1986 at William Blair & Co., an investment banking firm, where she held the position of principal, corporate finance from 1992 to 1997, focusing on specialty retail, catalog and distribution businesses in corporate finance.
Collins has been a member of the board of Integrys Energy Group since 2011, and currently serves as the chair of its governance committee and as member of its audit committee. Collins was a director of CDW, a provider of integrated IT solutions, from 1996 to 2007 and served as the chair of the audit committee and, for a period, as a member of the compensation committee. She was a board member of Coldwater Creek, a specialty retailer of women’s apparel, accessories, jewelry and gift items, from 1997 to 2004. Collins also served on the board of Molex, a global manufacturer of electronics, electrical and fiber optic interconnection products and systems, from 2003 to 2013, as well as a member of its audit committee and nominating and corporate governance committee. She served as a board member of Bucyrus International from 2009 to 2011, including as a member of its audit committee.
Collins serves on the boards of several civic organizations and private companies. She has been a member of the advisory board of Svoboda Capital Partners since 2007.